These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31923586)

  • 21. Direct-to-consumer genetic testing for predicting sports performance and talent identification: Consensus statement.
    Webborn N; Williams A; McNamee M; Bouchard C; Pitsiladis Y; Ahmetov I; Ashley E; Byrne N; Camporesi S; Collins M; Dijkstra P; Eynon N; Fuku N; Garton FC; Hoppe N; Holm S; Kaye J; Klissouras V; Lucia A; Maase K; Moran C; North KN; Pigozzi F; Wang G
    Br J Sports Med; 2015 Dec; 49(23):1486-91. PubMed ID: 26582191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selling direct-to-consumer epigenetic tests: are we ready?
    Dupras C; Beauchamp E; Joly Y
    Nat Rev Genet; 2020 Jun; 21(6):335-336. PubMed ID: 31992869
    [No Abstract]   [Full Text] [Related]  

  • 23. Direct-to-consumer genetic testing in Slovenia: availability, ethical dilemmas and legislation.
    Vrecar I; Peterlin B; Teran N; Lovrecic L
    Biochem Med (Zagreb); 2015; 25(1):84-9. PubMed ID: 25672471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consumer Perspectives on Access to Direct-to-Consumer Genetic Testing: Role of Demographic Factors and the Testing Experience.
    Gollust SE; Gray SW; Carere DA; Koenig BA; Lehmann LS; McGUIRE AL; Sharp RR; Spector-Bagdady K; Wang NA; Green RC; Roberts JS;
    Milbank Q; 2017 Jun; 95(2):291-318. PubMed ID: 28589610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patients Armed With Their Own Genetic Data Raise Tough Questions.
    Storrs C
    Health Aff (Millwood); 2018 May; 37(5):690-693. PubMed ID: 29733706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct-to-consumer DNA testing and the GP.
    Trent R
    Aust Fam Physician; 2014 Jul; 43(7):436-9. PubMed ID: 25006602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growing complexity of (expanded) carrier screening: Direct-to-consumer, physician-mediated, and clinic-based offers.
    Chokoshvili D; Vears DF; Borry P
    Best Pract Res Clin Obstet Gynaecol; 2017 Oct; 44():57-67. PubMed ID: 28302443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic counselling legislation and practice in cancer in EU Member States.
    McCrary JM; Van Valckenborgh E; Poirel HA; de Putter R; van Rooij J; Horgan D; Dierks ML; Antonova O; Brunet J; Chirita-Emandi A; Colas C; Dalmas M; Ehrencrona H; Grima C; Janavičius R; Klink B; Koczok K; Krajc M; Lace B; Leitsalu L; Mistrik M; Paneque M; Primorac D; Roetzer KM; Ronez J; Slámová L; Spanou E; Stamatopoulos K; Stoklosa T; Strang-Karlsson S; Szakszon K; Szczałuba K; Turner J; van Dooren MF; van Zelst-Stams WAG; Vassallo LM; Wadt KAW; Žigman T; Ripperger T; Genuardi M; Van den Bulcke M; Bergmann AK
    Eur J Public Health; 2024 Aug; 34(4):666-675. PubMed ID: 38905592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Living at Risk: Factors That Affect the Experience of Direct-to-Consumer Genetic Testing.
    Oliveri S; Renzi C; Masiero M; Pravettoni G
    Mayo Clin Proc; 2015 Oct; 90(10):1323-6. PubMed ID: 26434959
    [No Abstract]   [Full Text] [Related]  

  • 30. Genetic testing for neurologic disorders.
    Schneider SA; Schneider UH; Klein C
    Semin Neurol; 2011 Nov; 31(5):542-52. PubMed ID: 22266891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "I would rather have it done by a doctor"-laypeople's perceptions of direct-to-consumer genetic testing (DTC GT) and its ethical implications.
    Schaper M; Wöhlke S; Schicktanz S
    Med Health Care Philos; 2019 Mar; 22(1):31-40. PubMed ID: 29705970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FDA Approves Direct-to-Consumer Cancer Genomics.
    Eissenberg JC
    Mo Med; 2018; 115(2):126. PubMed ID: 30228700
    [No Abstract]   [Full Text] [Related]  

  • 33. The dawn of consumer-directed testing.
    Ramos E; Weissman SM
    Am J Med Genet C Semin Med Genet; 2018 Mar; 178(1):89-97. PubMed ID: 29512889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Information Provided to Consumers about Direct-to-Consumer Nutrigenetic Testing.
    De S; Pietilä AM; Iso-Touru T; Hopia A; Tahvonen R; Vähäkangas K
    Public Health Genomics; 2019; 22(5-6):162-173. PubMed ID: 31779000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Don’t Try This at Home: the FDA’s Restrictive Regulation of Home Testing Devices.
    Baird S
    Duke Law J; 2017 Nov; 67(2):383-426. PubMed ID: 29469551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct-to-consumer genetic testing: a systematic review of european guidelines, recommendations, and position statements.
    Rafiq M; Ianuale C; Ricciardi W; Boccia S
    Genet Test Mol Biomarkers; 2015 Oct; 19(10):535-47. PubMed ID: 26313927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 23andMe and the FDA.
    Annas GJ; Elias S
    N Engl J Med; 2014 Mar; 370(11):985-8. PubMed ID: 24520936
    [No Abstract]   [Full Text] [Related]  

  • 38. Consumer alert: ethical issues raised by the sale of genetic tests directly to consumers.
    Wasson K
    Am J Bioeth; 2008 Jun; 8(6):16-8. PubMed ID: 18726774
    [No Abstract]   [Full Text] [Related]  

  • 39. What is at stake in the predictive genetic testing of children?
    Clarke A
    Fam Cancer; 2010 Mar; 9(1):19-22. PubMed ID: 19544011
    [No Abstract]   [Full Text] [Related]  

  • 40. Anxiety delivered direct-to-consumer: are we asking the right questions about the impacts of DTC genetic testing?
    Oliveri S; Howard HC; Renzi C; Hansson MG; Pravettoni G
    J Med Genet; 2016 Dec; 53(12):798-799. PubMed ID: 27647845
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.